TURN-COVID Biobank: The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

June 14, 2024

Study Completion Date

June 14, 2024

Conditions

COVID-19

Interventions

DRUG

casirivimab with imdevimab

Monoclonal antibody

DRUG

sotrovimab

Monoclonal antibody

DRUG

molnupiravir

antiviral agent

Trial Locations (4)

RECRUITING

Amsterdam University Medical centre - VUMC, Amsterdam

RECRUITING

Amsterdam University Medical Centre, Amsterdam

RECRUITING

Leiden universitair medisch centrum, Leiden

RECRUITING

Radboud Universitair Medisch Centrum, Nijmegen

All Listed Sponsors

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER